Stefano Petruzzelli

Parma, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Objectively Measured Physical Activity as a COPD Clinical Trial Outcome.

Objectively Measured Physical Activity as a COPD Clinical Trial Outcome.

Journal: Chest

Published: April 30, 2020

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.

Journal: American journal of respiratory and critical care medicine

Published: March 19, 2020

Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.

Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.

Journal: American journal of respiratory and critical care medicine

Published: December 10, 2019

Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.

Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.

Journal: Respiratory research

Published: October 17, 2019

Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials.

Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials.

Journal: Lancet (London, England)

Published: June 13, 2019

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA.

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA.

Journal: International journal of chronic obstructive pulmonary disease

Published: March 19, 2019

Asthma progression and mortality: the role of inhaled corticosteroids.

Asthma progression and mortality: the role of inhaled corticosteroids.

Journal: The European respiratory journal

Published: March 08, 2019

Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation.

Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation.

Journal: The European respiratory journal

Published: January 24, 2019

Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations.

Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations.

Journal: The European respiratory journal

Published: January 21, 2019

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal.

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal.

Journal: International journal of chronic obstructive pulmonary disease

Published: December 28, 2018

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids.

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids.

Journal: International journal of chronic obstructive pulmonary disease

Published: November 23, 2018

Inhaled corticosteroid containing combinations and mortality in COPD.

Inhaled corticosteroid containing combinations and mortality in COPD.

Journal: The European respiratory journal

Published: July 02, 2018

Showing 1-12 of 25

Last Updated: 09/26/2026